Effect of miR-126 on cell cycle regulation and prognosis of lung cancer patients

Journal of Practical Oncology

Volumn 29, Issue 5, 2014, Pages 440-445

  Li, Xun Guang ^a   Wan, Gong Shan ^a   Liang, Yan Xia ^a  

^a Department of Respiration Ganyu County People's Hospital   (China)

Author keywords

Cell cycle; Cell proliferation; Lung neoplasms pathology; MicroRNAs; Polymerase chain reaction; Prognosis; Survival rate; Transfection

Indexed keywords

MICRORNA 126;

ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL VIABILITY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; LUNG CARCINOGENESIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84908071870     PISSN: 10011692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Guz M, Rivero-Müller A, Okoń E, et al. MicroRNAs-role in lung cancer[J]. Dis Markers, 2014, 2014: 218169.
2. Tan W, Gu J, Huang M, et al. Epigenetic analysis of micro RNA genes in tumors from surgically resected lung cancerpatients and association with survival[J]. Mol Carcinog, 2014[Epub ahead of print]. doi: 10.1002/mc.22149.
3. Gong Z, Yang J, Li J, et al. Novel insights into the role of microRNA in lung cancer resistance to treatment and targeted therapy[J]. Curr Cancer Drug Targets, 2014, 14(3): 241-258.
4. Shi WY, Liu KD, Xu SG, et al. Gene expression analysis of lung cancer[J]. Eur Rev Med Pharmacol Sci, 2014, 18(2): 217-228.
5. Ebrahimi F, Gopalan V, Smith RA, et al. miR-126 in human cancers: clinical roles and current perspectives[J]. Exp Mol Pathol, 2014, 96(1): 98-107.
6. Liu Y, Zhou Y, Feng X, et al. Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer[J]. Genes Chromosomes Cancer, 2014, 53(4): 358-365.
7. Yu Q, Liu SL, Wang H, et al. miR-126 Suppresses the proliferation of cervical cancer cells and alters cell sensitivity to the chemotherapeutic drug bleomycin[J]. Asian Pac J Cancer Prev, 2013, 14(11): 6569-6572.
8. Bandi N, Zbinden S, Gugger M, et al. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer[J]. Cancer Res, 2009, 69(13): 5553-5559.
9. Takahashi Y, Forrest AR, Maeno E, et al. MiR-107 and MiR-185 can induce cell cycle arrest in human non-small cell lung cancer cell lines[J]. PLoS One, 2009, 4(8): e6677.
10. Li B, Ren S, Li X, et al. MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer[J]. Lung Cancer, 2014, 83(2): 146-153.
11. Liu ZL, Wang H, Liu J, et al. MicroRNA-21(miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN[J]. Mol Cell Biochem, 2013, 372(1-2): 35-45.
12. Fish JE, Santoro MM, Morton SU, et al. miR-126 regulates angiogenic signaling and vascular integrity[J]. Dev Cell, 2008, 15(2): 272-284.
13. Zernecke A, Bidzhekov K, Noels H, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection[J]. Sci Signal, 2009, 2(100): ra81.
14. Li Z, Lu J, Sun M, et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations[J]. Proc Natl Acad Sci U S A, 2008, 105(40): 15535-15540.
15. Yang J, Lan H, Huang X, et al. MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients[J]. PLoS One, 2012, 7(8): e42978.
16. Miko E, Margitai Z, Czimmerer Z, et al. miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5[J]. FEBS Lett, 2011, 585(8): 1191-1196.
17. Jusufovi■ E, Rijavec M, Keser D, et al. let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non-small-cell lung cancer[J]. PLoS One, 2012, 7(9): e45577.
18. Miko E, Margitai Z, Czimmerer Z, et al. miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5[J]. FEBS Lett, 2011, 585(8): 1191-1196.